Zolmitriptan for treatment of migrainous vertigo: A pilot randomized placebo-controlled trial

Neurology

Volumn 60, Issue 5, 2003, Pages 882-883

  Neuhauser, Hannelore ^a,b   Radtke, A ^a   Von Brevern, M ^a   Lempert, T ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIMENHYDRINATE; PARACETAMOL; PLACEBO; ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0037432271     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000049476.40047.A3     Document Type: Article

References (7)

1. Baloh RW. Neurotology of migraine. Headache 1997;37:615-621.
2. Evans RW, Baloh RW. Episodic vertigo and migraine. Headache 2001;41:604-605.
3. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999;246:883-892.
4. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992;32:300-304.
5. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18:350-354.
6. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo and migrainous vertigo. Neurology 2001;56:436-441.
7. Olesen J. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):9-96.